Life support withdrawal for terminally ill: IMA flags concerns, says it will put doctors under stress

The Indian Medical Association has expressed concerns over new guidelines that put the responsibility of deciding on life support withdrawal on doctors. The draft suggests a dual-board system and family consent for terminally ill patients. This aims to help families make informed choices but may stress doctors.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qgv3rJ8
via IFTTT

Read More

Venus Remedies get market authorisations for two cancer drugs from Morocco, Philippines

Venus Remedies Ltd has received marketing authorisations for two key oncology drugs, carboplatin and bortezomib, from Morocco and the Philippines. These approvals are part of the company's strategy to expand its oncology range and meet the growing global demand for cancer treatments, strengthening its position in Southeast Asia and Africa.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sqeOPVY
via IFTTT

Read More

Linking spurious drugs with legitimate manufacturers has severe reputational, financial impact: IPA

The Indian Pharmaceutical Alliance (IPA) has called for a clear distinction between spurious and sub-standard drugs following a CDSCO report listing over 50 products as 'not of standard quality'. Major drug firms like Sun Pharma and Glenmark assert that flagged medicines are counterfeits, not their products. IPA emphasizes the need to protect India's reputation as a reliable medicine supplier.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AB0WwEI
via IFTTT

Read More

Regulatory, policy reforms crucial for future of India's pharma R&D: Report

India's regulatory and policy reforms are crucial for the future of pharmaceutical R&D, streamlining approval processes and strengthening IP protections. Despite significant transformation, challenges like inadequate drug regulation capacity and high compliance costs hinder growth. The report suggests promoting India as a hub for pharmaceutical research and development.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sWd74oz
via IFTTT

Read More

Health ministry comes up with new draft guidelines on passive euthanasia

The Union Health Ministry's draft guidelines on passive euthanasia suggest doctors should make considered decisions on withdrawing life support for terminally ill patients based on specific conditions. The guidelines aim to ensure decisions are in the patient's best interests, considering factors like brainstem death and informed refusal by the patient or their kin.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kKW1Tel
via IFTTT

Read More

Monkeypox in India: Key do's and don'ts you need to follow

The Health Ministry's guidelines for Monkeypox in India stress isolation, testing, and public awareness while urging prompt reporting of cases.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QJ9s0SU
via IFTTT

Read More

Medical bills in India are rapidly becoming bigger, reveals new index

The ACKO India Health Insurance Index 2024 reveals a 14% annual rise in healthcare costs, with 62% of expenses paid out of pocket. Delhi leads in kidney disease claims, while Kolkata and Mumbai see high heart disease claims. It emphasised the need for improved health coverage to protect individuals from unexpected health crises.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xY9Z6tD
via IFTTT

Read More